BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8615593)

  • 1. Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells identification of a transfectant with increased tumorigenicity and invasiveness.
    Sun Y; Kim H; Parker M; Stetler-Stevenson WG; Colburn NH
    Anticancer Res; 1996; 16(1):1-7. PubMed ID: 8615593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3.
    Bian J; Wang Y; Smith MR; Kim H; Jacobs C; Jackman J; Kung HF; Colburn NH; Sun Y
    Carcinogenesis; 1996 Sep; 17(9):1805-11. PubMed ID: 8824499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3.
    Sun Y; Hegamyer G; Colburn NH
    Cancer Res; 1994 Mar; 54(5):1139-44. PubMed ID: 8118794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation.
    Sun Y; Hegamyer G; Kim H; Sithanandam K; Li H; Watts R; Colburn NH
    J Biol Chem; 1995 Aug; 270(33):19312-9. PubMed ID: 7642607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic consequences of down-modulating TIMP expression in 3T3 cells with antisense RNA.
    Denhardt DT; Khokha R; Yagel S; Overall CM; Parhar RS
    Matrix Suppl; 1992; 1():281-5. PubMed ID: 1480038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells.
    Pennie WD; Hegamyer GA; Young MR; Colburn NH
    Cell Growth Differ; 1999 Apr; 10(4):279-86. PubMed ID: 10319998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells.
    Colburn NH; Smith BM; Wendel EJ; Dowjat WK; Shimada T
    Cancer Res; 1988 Mar; 48(5):1195-200. PubMed ID: 3342399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines.
    Qing J; Maher VM; Tran H; Argraves WS; Dunstan RW; McCormick JJ
    Oncogene; 1997 Oct; 15(18):2159-68. PubMed ID: 9393974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMP-3 gene transfection suppresses invasive and metastatic capacity of human hepatocarcinoma cell line HCC-7721.
    Zhang H; Wang YS; Han G; Shi Y
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):487-91. PubMed ID: 17897911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of TIMP-2 gene transfection on biological behaviors of a metastatic human lung carcinoma cell line].
    Li H; Fang W; Shi Z
    Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):652-6. PubMed ID: 9772531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.
    Wang M; Liu YE; Greene J; Sheng S; Fuchs A; Rosen EM; Shi YE
    Oncogene; 1997 Jun; 14(23):2767-74. PubMed ID: 9190892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
    Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
    Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.